Quick Answer
VOLITIONRX LTD reported Net Income of -$23.36 million for fiscal year 2025.
VOLITIONRX LTD Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$23.36M | +13.4% |
| 2024 | -$26.97M | +24.4% |
| 2023 | -$35.68M | -16.6% |
| 2022 | -$30.60M | -13.4% |
| 2021 | -$26.99M | -32.3% |
| 2020 | -$20.40M | -26.7% |
| 2019 | -$16.10M | +10.6% |
| 2018 | -$18.01M | -21.9% |
| 2017 | -$14.77M | -24.1% |
| 2016 | -$11.91M | -24.9% |
| 2015 | -$9.53M | -16.0% |
| 2014 | -$8.21M | -121.4% |
| 2013 | -$3.71M | +9.1% |
| 2012 | -$4.08M | -56.5% |
| 2011 | -$2.61M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$5.38M | +7.6% | +14.4% |
| June 30, 2025 | -$6.28M | +10.0% | -15.9% |
| March 31, 2025 | -$5.42M | +35.2% | +6.8% |
| September 30, 2024 | -$5.82M | +31.1% | +16.7% |
| June 30, 2024 | -$6.99M | +26.9% | +16.5% |
| March 31, 2024 | -$8.37M | +5.7% | +1.0% |
| September 30, 2023 | -$8.45M | -8.2% | +11.5% |
| June 30, 2023 | -$9.55M | -23.5% | -7.6% |
- VOLITIONRX LTD showed an increase of +13.4% in Net Income compared to the prior fiscal year.
- Over the 2011–2025 period, VOLITIONRX LTD’s net income has declined by 795.4% (from -$2.61 million to -$23.36 million).
- The most recent figure is from VOLITIONRX LTD’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: